KERYX BIOPHARMACEUTICALS INC
S-1/A, EX-23.3, 2000-06-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: KERYX BIOPHARMACEUTICALS INC, S-1/A, EX-23.1, 2000-06-29
Next: KERYX BIOPHARMACEUTICALS INC, S-1/A, EX-27, 2000-06-29



<PAGE>

                                                                    Exhibit 23.3


                                                   [Logo of PA Consulting Group]


30 June 2000

The Directors
Keryx Biopharmaceuticals, Inc.
216 Jaffa Road
Sh'arei Ha'ir
Jerusalem
Israel 94383


Dear Sirs

Keryx Biopharmaceuticals

We hereby consent to the references to our experts report contained in the
Registration Statement on Form S-1 of Keryx Biopharmaceuticals, Inc. and to the
reference to us under the heading "Experts" in the preliminary prospectus, which
is a part of such Registration Statement.

We hereby consent for the purposes of section 13(1)(g) of the Public Offers of
Securities Regulations 1995 to the issue of the preliminary prospectus to be
issued by you in relation to your admission to trading on the Nasdaq National
Market and the Alternative Investment Market of the London Stock Exchange, a
proof of which is annexed hereto and initialled by us for the purposes of
identification, with the inclusion therein of a copy of our report and to the
references to our name in the form and context in which they appear.


Yours faithfully,
For and on behalf of
PA STRATEGY PARTNERS LIMITED


/s/ Keith Redpath

Keith Redpath
Management Group - PA










© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission